Literature DB >> 18762288

Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection.

Nicole D Pecora1, Scott A Fulton, Scott M Reba, Michael G Drage, Daimon P Simmons, Nancy J Urankar-Nagy, W Henry Boom, Clifford V Harding.   

Abstract

Mycobacterium tuberculosis and M. bovis BCG infect APCs. In vitro, mycobacteria inhibit IFN-gamma-induced MHC-II expression by macrophages, but the effects of mycobacteria on lung APCs in vivo remain unclear. To assess MHC-II expression on APCs infected in vivo, mice were aerosol-infected with GFP-expressing BCG. At 28 d, approximately 1% of lung APCs were GFP+ by flow cytometry and CFU data. Most GFP+ cells were CD11b(high)/CD11c(neg-mid) lung macrophages (58-68%) or CD11b(high)/CD11c(high) DCs (28-31%). Lung APC MHC-II expression was higher in infected mice than naïve mice. Within infected lungs, however, MHC-II expression was lower in GFP+ cells than GFP- cells for both macrophages and DCs. MHC-II expression was also inhibited on purified lung macrophages and DCs that were infected with BCG in vitro. Thus, lung APCs that harbor mycobacteria in vivo have decreased MHC-II expression relative to uninfected APCs from the same lung, possibly contributing to evasion of T cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762288      PMCID: PMC2653222          DOI: 10.1016/j.cellimm.2008.07.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  32 in total

1.  Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Ian M Orme; Mercedes Gonzalez-Juarrero
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

2.  Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.

Authors:  E H Noss; C V Harding; W H Boom
Journal:  Cell Immunol       Date:  2000-04-10       Impact factor: 4.868

3.  Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  J A Hamerman; A Aderem
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

4.  Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice.

Authors:  R Reljic; C Di Sano; C Crawford; F Dieli; S Challacombe; J Ivanyi
Journal:  Tuberculosis (Edinb)       Date:  2004-12-23       Impact factor: 3.131

5.  Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.

Authors:  S A Fulton; T D Martin; R W Redline; W Henry Boom
Journal:  Am J Respir Cell Mol Biol       Date:  2000-03       Impact factor: 6.914

6.  Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling.

Authors:  Pierre-Yves Bochud; Thomas R Hawn; Alan Aderem
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.

Authors:  Norbert Reiling; Christoph Hölscher; Alexandra Fehrenbach; Svenja Kröger; Carsten J Kirschning; Sanna Goyert; Stefan Ehlers
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.

Authors:  Adam J Gehring; Roxana E Rojas; David H Canaday; David L Lakey; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.

Authors:  Rish K Pai; Marilyn Convery; Thomas A Hamilton; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-gamma without inhibiting STAT1 function.

Authors:  Eleanor Z Kincaid; Joel D Ernst
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  32 in total

1.  Suppression of dendritic cell-mediated responses by genes in calcium and cysteine protease pathways during Mycobacterium tuberculosis infection.

Authors:  Jhalak Singhal; Neha Agrawal; Mohit Vashishta; N Gayatri Priya; Brijendra K Tiwari; Yogendra Singh; Rajagopal Raman; Krishnamurthy Natarajan
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

Review 2.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

3.  Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells.

Authors:  Morgan A Reuter; Nicole D Pecora; Clifford V Harding; David H Canaday; David McDonald
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  Surfactant protein-A inhibits mycoplasma-induced dendritic cell maturation through regulation of HMGB-1 cytokine activity.

Authors:  Julie G Ledford; Bernice Lo; Michele M Kislan; Joseph M Thomas; Katherine Evans; Derek W Cain; Monica Kraft; Kristi L Williams; Jo Rae Wright
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

5.  BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.

Authors:  Pearl Bakhru; Natalie Sirisaengtaksin; Emily Soudani; Seema Mukherjee; Arshad Khan; Chinnaswamy Jagannath
Journal:  Cell Immunol       Date:  2013-12-11       Impact factor: 4.868

Review 6.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.

Authors:  Clifford V Harding; W Henry Boom
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

7.  Optimization of a whole blood intracellular cytokine assay for measuring innate cell responses to mycobacteria.

Authors:  Muki S Shey; E Jane Hughes; Marwou de Kock; Charlene Barnard; Lynnett Stone; Tobias R Kollmann; Willem A Hanekom; Thomas J Scriba
Journal:  J Immunol Methods       Date:  2011-12-01       Impact factor: 2.303

8.  SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice.

Authors:  Julie G Ledford; Hisatsugu Goto; Erin N Potts; Simone Degan; Hong Wei Chu; Dennis R Voelker; Mary E Sunday; George J Cianciolo; William M Foster; Monica Kraft; Jo Rae Wright
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge.

Authors:  Megan E Ermler; Ekaterina Yerukhim; Jill Schriewer; Stefan Schattgen; Zachary Traylor; Adam R Wespiser; Daniel R Caffrey; Zhijian J Chen; Charles H King; Michael Gale; Marco Colonna; Katherine A Fitzgerald; R Mark L Buller; Amy G Hise
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  Impaired immune responses in the lungs of aged mice following influenza infection.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Respir Res       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.